Prior to this legislation, pharmacies in Alabama were prohibited from selling any CBD products even though CBD could be purchased from a variety of retailers throughout the state.
While hemp-derived CBD had been federally legalized in 2018, CBD was still classified as marijuana under Alabama law. Because of this, CBD had been regulated as a Schedule 1 controlled substance alongside illicit substances like opioids and heroin.
With the passing of SB225, Alabama has removed CBD as a Schedule 1 controlled substance, following suit with the federal government’s reclassification of CBD. This will help to further normalize the industry and could help to establish a much-needed framework for regulating the quality and safety of CBD products.
As pharmacies across the state begin to stock their shelves with CBD products, residents of Alabama can soon purchase a variety of CBD products from the convenience of their local pharmacy.